With its state-of-the-art facilities, Synex also has the capabilities to perform process development and scale-up chemistry. Our chemists have many years of experience in the industry and have specialised in the development of synthetic routes to complex organic molecules used in preclinical studies.

We have the knowledge and facilities to develop and optimise existing processes or design new synthetic routes with fewer steps and increased atom efficiency, improving yields and reducing costs. Using our in-house facilities and talented chemists, we can scale up to 10kg or outsource larger quantities to trusted partners.

As part of our integrated production service, we can also organise seamless process transfer to the client’s pilot plant or other manufacturing facilities.

Our capabilities include:

• Scale-up of intermediates and building blocks
• Scale-up of preclinical drug candidates
• Development of a scalable and reproducible manufacturing process
• Low temperature reactions on 20L scale (-80°C)

Read about our chemical synthesis work.